NASDAQ
Mayne Pharma Group Limited (MAYNF) has a current ratio of 1.35x as of Monday, May 25, 2026. This represents a 9.25% decrease compared to its 12-month average of 1.49x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.